When a drug on the market is determined to be dangerous in some way, it may be recalled. This can be because the drug was not advertised properly, because a specific batch or all of the drug available is contaminated or compromised, new side effects are discovered, or because the drug in the packages on the market is not the drug labeled on the packages. If a drug you currently take is recalled, stop taking it and contact your healthcare provider or local pharmacy for further instruction.
Drug manufacturers have the responsibility to disclose all potential side effects of their products. They must be disclosed to doctors who may prescribe the products to patients and to patients who may take the drugs. By providing this information, drug companies make it possible for doctors to weigh the benefits and potential risks of a particular medication before prescribing it to a patient and patients can consider whether the benefits outweigh the risks before deciding whether or not to take the medication.
Numerous claims have been filed against Johnson & Johnson and Janssen Pharmaceuticals, the manufacturers of diabetes medication Invokana. These claims allege that the manufacturers did not adequately warn doctors and their patients of the drug’s potential side effects, which include an increased risk of kidney failure, foot and leg amputations, and ketoacidosis.
A state inspection of a pharmacy in Fayetteville, North Carolina, has led to the recall of more than 600 drugs in a variety of dosages and formulations, officials announced in late March. The U.S. Food and Drug Administration (FDA) and the North Carolina Board of Pharmacy (NCBOP) have issued a warning to medical professionals and patients regarding all compounded drugs made or distributed by the Prescription Center pharmacy, which has been since shut down.
Compounded Drug Recall
Though the manufacturer has come under fire for defective devices in the past, this year the da Vinci Sp Intuitive single port robot system used in surgical procedures is expected to hit the consumer market, according to MedGadget.com. The system is designed to allow for single-incision surgeries, and is a competitor to manufacturing giant Titan.
A federal multidistrict litigation panel has consolidated 21 Xarelto cases in the Eastern District of Louisiana. Eight of these cases were originally filed in the Southern District of Illinois. The others came from Louisiana, Florida, Kentucky, New York, Utah, Vermont and West Virginia. Writing on behalf of a seven-member panel, Judge Sarah Vance concluded that the cases all presented common factual issues, even though there were some differences, such as dosage amount and medical history.
Lupron is a hormonal regulator that has several dangerous, if not oft-publicized side effects of which every patient should be aware. The drug is prescribed to help slow early-onset puberty in teenagers, to men who exhibit signs of prostate cancer, and to help treat women with endometriosis, a rare condition in which the lining of the uterus grows outside the actual uterus. According to the U.S.
The product first hailed as a miracle weight-loss drug and subsequently pulled from the market when its dangers became apparent has resurfaced, albeit in another format. But the new drug has some of the same health concerns, and some new ones as well.
Most drugs used to treat chronic issues dealing with digestion or heart issues carry some risk of side effects, but some are worse than others. Lisinopril is a angiotensin-converting enzyme (ACE) inhibitor, used to treat congestive heart failure, hypertension, and reduce the risk of heart attack. It has been commonly prescribed since the FDA first approved it for patient use in the early 1990s.
Last year, a Supreme Court ruling came down that will affect thousands of Americans, even if they were not aware of the ruling. Building on a ruling that declared manufacturers of medical devices could, in some cases, enjoy immunity status if the device turned out to be defective, last year’s case determined that no patient could challenge a manufacturer in state court if it had been approved at the federal level.